ArticleCancers2023
Explainable CAD System for Classification of Acute Lymphoblastic Leukemia Based on a Robust White Blood Cell Segmentation.
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 25 citations in OpenAlex.
- Demystifying Deep Learning Decisions in Leukemia Diagnostics Using Explainable AI.Diagnostics (Basel, Switzerland) · 2026Article
- Advanced leukocyte classification using attention mechanisms and dual channel U-Net architecture.Scientific reports · 2025Article
- Article
- An explainable deep learning-based feature fusion model for acute lymphoblastic leukemia diagnosis and severity assessment.Frontiers in medicine · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukemia is a significant health challenge, with high incidence and mortality rates. Computer-aided diagnosis (CAD) has emerged as a promising approach. However, deep-learning methods suffer from the "black box problem", leading to unreliable diagnoses. This research proposes an Explainable AI (XAI) Leukemia classification method that addresses this issue by incorporating a robust White Blood Cell (WBC) nuclei segmentation as a hard attention mechanism. The segmentation of WBC is achieved by combining image processing and U-Net techniques, resulting in improved overall performance. The segmented images are fed into modified ResNet-50 models, where the MLP classifier, activation functions, and training scheme have been tested for leukemia subtype classification. Additionally, we add visual explainability and feature space analysis techniques to offer an interpretable classification. Our segmentation algorithm achieves an Intersection over Union (IoU) of 0.91, in six databases. Furthermore, the deep-learning classifier achieves an accuracy of 99.9% on testing. The Grad CAM methods and clustering space analysis confirm improved network focus when classifying segmented images compared to non-segmented images. Overall, the proposed visual explainable CAD system has the potential to assist physicians in diagnosing leukemia and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.